1. CURRENT THERAPY OF SECONDARY CNS INVOLVEMENT IN MALIGNANT LYMPHOMA: DATA FROM A MULTICENTER PROSPECTIVE INTERNATIONAL REGISTRY. (June 2017) Authors: Korfel, A.; Schroers, R.; Schlegel, U.; Schmitz, N.; Hofer, S.; Bairey, O.; Schmidt‐Hieber, M.; Le Coutre, P.; Janz, M.; Reimer, P.; Martus, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. New patient derived lymphoma xenograft (PDX) panel for drug development, immuno-oncology and translational research. (October 2022) Authors: Brzezicha, B.; Becker, M.; Stecklum, M.; Conrad, T.; Janz, M.; Bittner, A.; Schmitt, C.A.; Hoffmann, J. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Patient-derived xenografts (PDX) from agressive haematological malignancies. (December 2016) Authors: Brzezicha, B.; Siegert, A.; Walther, W.; Fichtner, I.; Hoffmann, J.; Karawajew, L.; Schmitt, C.; Janz, M. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. S287: FACTORS INFLUENCING AUTOLOGOUS LYMPHOCYTE COLLECTIONS FOR CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS – THE ROLE OF T-CELL SENESCENCE. (23rd June 2022) Authors: Vucinic, V.; Tumewu, T.; Brückner, M.; Jentzsch, M.; Ramdohr, F.; Buhmann, R.; Remane, Y.; Hoffmann, S.; Janz, M.; Penack, O.; Vogtmann, G.; Ruschpler, E.; Bullinger, L.; Keller, U.; Cross, M.; Schwind, S.; Herling, M.; Franke, G.-N.; Bach, E.; Reinhard, H. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗